NCT05157100View on ClinicalTrials.gov

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 19, 2021

Primary Completion Date

September 15, 2023

Study Completion Date

September 15, 2023

Conditions
Cervical Dystonia
Interventions
DRUG

Ingrezza Pill

Participants will receive Ingrezza 40 mg and 80 mg tablets for 12 weeks.

Trial Locations (1)

43054

The Orthopedic foundation, New Albany

All Listed Sponsors
lead

The Orthopedic Foundation

OTHER

NCT05157100 - Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia | Biotech Hunter | Biotech Hunter